首页> 外文期刊>Systems biology in reproductive medicine >Sperm and testis mediated DNA transfer as a means of gene therapy.
【24h】

Sperm and testis mediated DNA transfer as a means of gene therapy.

机译:精子和睾丸介导的DNA转移是基因治疗的一种手段。

获取原文
获取原文并翻译 | 示例
       

摘要

Assisted reproductive technologies (ART) have revolutionized the treatment of infertility. However, many types of infertility may still not be addressable by ART. With recent successes in identifying many of the genetic factors responsible for male infertility and the future prospect of whole individual human genome sequencing to identify disease causing genes, the possible use of gene therapy for treating infertility deserves serious consideration. Gene therapy in the sperm and testis offers both opportunities and obstacles. The opportunities stem from the fact that numerous different approaches have been developed for introducing transgenes into the sperm and testis, mainly because of the interest in using sperm mediated gene transfer and testis mediated gene transfer as ways to generate transgenic animals. The obstacles arise from the fact that it may be very difficult to carry out gene therapy of the testis and sperm without also affecting the germline. Here we consider new developments in both sperm and testis mediated gene transfer, including the use of viral vectors, as well as the technical and ethical challenges facing those who would seek to use these approaches for gene therapy as a way to treat male infertility.
机译:辅助生殖技术(ART)彻底改变了不育症的治疗方法。但是,许多类型的不育症可能仍无法通过ART解决。随着最近成功鉴定出许多导致男性不育的遗传因素以及整个人类基因组测序以鉴定致病基因的未来前景,基因治疗治疗不育症的可能用途值得认真考虑。精子和睾丸的基因治疗既有机遇也有障碍。机会源于以下事实:已开发出许多不同的方法将转基因引入精子和睾丸,这主要是因为人们对使用精子介导的基因转移和睾丸介导的基因转移作为产生转基因动物的方式感兴趣。障碍来自以下事实,即在不影响种系的情况下进行睾丸和精子的基因治疗可能非常困难。在这里,我们考虑了精子和睾丸介导的基因转移方面的新发展,包括病毒载体的使用,以及那些寻求将这些方法用于基因治疗以治疗男性不育症的人们所面临的技术和伦理挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号